Matt is a senior radiotherapist, the former Head of Cancer Transformation for AXA Health UK, a board-level director and founder and CEO of The Health Value Alliance.
In addition, Matt is co-chair of the All.Can International Research and Evidence Working Group and co-author of a variety of publications. Matt also co-sponsors a number of cancer outcomes research programmes, is a director in a number of start-up med-tech companies and an advisor to a number of international cancer quality design initiatives.
Prior to AXA, Matt was International Director of Strategy and Health Economics for GenesisCare and Cancer Healthcare Manager for Bupa, UK.
Matt has a particular interest in developing global quality standards and on advancing the field of AI-supported predictive modelling in cancer.